Internal Medicine, Endocrinology, Diabetes, & Metabolism · Brooklyn, NY
NPI
1922057397
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
5
Medicare group memberships
Hospitals
1
Hospital affiliations
1423 Bedford Ave
Brooklyn, NY, 11216
Phone (718) 773-0883
Groups this clinician bills Medicare through
Medicare paid, 2024
$285K
3,176 services
Medicare patients, 2024
348
Average age 72
Drug cost, 2024
$3.7M
8,511 prescriptions
Company payments, 2025
$7,687
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Saka A Kazeem was code 99214 (office e&m - established), 764 times for 244 patients. In total Saka A Kazeem billed 3,176 services in 71 codes, and Medicare paid $285K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-08-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 764 | 244 | $119.22 | $91K |
| 99213 Office E&M - Established | Office | 241 | 133 | $81.44 | $20K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 200 | 143 | $15.33 | $3,067 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 179 | 111 | $45.19 | $8,089 |
| 76981 Ultrasound - Nonspecific | Office | 162 | 137 | $101.76 | $16K |
| 76536 Ultrasound - Nonspecific | Office | 141 | 125 | $105.91 | $15K |
| 36415 Venipuncture Blood Collection | Office | 140 | 105 | $8.65 | $1,211 |
| 95251 Test - Miscellaneous | Office | 116 | 56 | $30.74 | $3,566 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 116 | 116 | $22.85 | $2,651 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 92 | 92 | $155.17 | $14K |
| 99215 Office E&M - Established | Office | 72 | 59 | $166.29 | $12K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 67 | 64 | $184.41 | $12K |
| 95923 Electrical Nerve Conductivity | Office | 65 | 65 | $118.29 | $7,689 |
| 95921 Electrical Nerve Conductivity | Office | 63 | 63 | $84.15 | $5,301 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 61 | 58 | $103.80 | $6,332 |
By year: 2022 $252K for 2,775 services; 2023 $280K for 2,799 services; 2024 $285K for 3,176 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 140 | 105 | $8.65 | $1,211 |
Medicare prescription drug claims, 2024
In 2024, the drug Saka A Kazeem prescribed most often to Medicare patients was Ozempic (Semaglutide), with 395 prescriptions and refills. In total Saka A Kazeem wrote 8,511 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 395 | 666 | 96 | $635K |
| Levothyroxine Sodium Generic | 306 | 789 | 99 | $3,704 |
| Atorvastatin Calcium Generic | 273 | 753 | 93 | $3,136 |
| Jardiance Empagliflozin | 250 | 566 | 81 | $329K |
| Amlodipine Besylate Generic | 249 | 622 | 77 | $1,732 |
| Metformin Hcl Generic | 225 | 562 | 78 | $4,143 |
| Gabapentin Generic | 178 | 329 | 50 | $1,959 |
| Mounjaro Tirzepatide | 178 | 263 | 46 | $279K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 156 | 332 | 45 | $23K |
| Kerendia Finerenone | 148 | 304 | 36 | $192K |
| Trulicity Dulaglutide | 137 | 269 | 40 | $264K |
| Rosuvastatin Calcium Generic | 134 | 317 | 46 | $1,995 |
| Simvastatin Generic | 134 | 278 | 29 | $821 |
| Losartan Potassium Generic | 133 | 394 | 51 | $1,384 |
| Easy Touch Alcohol Prep Pads Alcohol Antiseptic Pads | 128 | 174 | 22 | $402 |
Brand drugs: 3,054 claims; generic drugs: 4,790 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Saka A Kazeem $7,687 ($7,687 in general payments such as food, travel and fees) from 24 companies. The largest payer was Cambridge Interventional LLC with $6,000.
| Company | Payments | Amount |
|---|---|---|
| Cambridge Interventional LLC | 1 | $6,000 |
| Esaote North America, Inc. | 1 | $514 |
| Xeris Pharmaceuticals, Inc. | 7 | $143 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $131 |
| Chiesi USA, Inc. | 4 | $119 |
| Phathom Pharmaceuticals, Inc. PHAT | 8 | $114 |
| Madrigal Pharmaceuticals MDGL | 3 | $92.68 |
| Lilly USA, LLC LLY | 3 | $74.48 |
| Amgen Inc. AMGN | 3 | $67.4 |
| CeQur Corporation | 1 | $66 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.